ATLAS / Macro Radar / Reporting / FBLG

FibroBiologics, Inc. (FBLG) reporting calendar

FibroBiologics, Inc. files periodic reports with the SEC as FBLG on Nasdaq. Atlas tracks 10 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
10 Jul 2026 – 8 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
30 Apr 2026
Reports on record
10

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 40 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open FBLG market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202630 Apr 202630 days0001193125-26-197858
10-K31 Dec 202524 Feb 202655 days0001193125-26-066965
10-Q30 Sep 202531 Oct 202531 days0001193125-25-260774
10-Q30 Jun 202531 Jul 202531 days0000950170-25-100917
10-Q31 Mar 202514 May 202544 days0001641172-25-010252
10-K31 Dec 202431 Mar 202590 days0001641172-25-001691
10-Q30 Sep 202412 Nov 202443 days0001493152-24-044736
10-Q30 Jun 20247 Aug 202438 days0001493152-24-030603
10-Q31 Mar 202414 May 202444 days0001493152-24-019225
10-K31 Dec 202329 Feb 202460 days0001493152-24-008361

Source: SEC EDGAR company submissions for CIK 0001958777. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.